Diclofenac

Diclofenac

SCHEMBL2216520

N.O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGS1PTGS2

The experimentally established mechanism targets of Diclofenac. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 known ✓ P35354 8/20 0.97
PTGS1 known ✓ P23219 2/20 0.97
CXCL8 P10145 4/20 0.97
TTR P02766 3/20 0.97
AKR1B10 O60218 1/20 0.97
UGT1A9 O60656 1/20 0.97
TRPA1 O75762 1/20 0.97
ABCB11 O95342 1/20 0.97
MT-CO2 P00403 1/20 0.97
ALB P02768 1/20 0.97
UGT1A6 P19224 1/20 0.97
UGT1A1 P22309 1/20 0.97
CXCR1 P25024 1/20 0.97
ADRA1A P35348 1/20 0.97
AGTR2 P50052 1/20 0.97
NR1I3 Q14994 1/20 0.97
SLC22A6 Q4U2R8 1/20 0.97
NR1H4 Q96RI1 1/20 0.97
UGT1A7 Q9HAW7 1/20 0.97
UGT1A10 Q9HAW8 1/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diclofenac SCHEMBL29354260 0.98 PTGS2 (1.00) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL996716 0.98 PTGS2 (1.00) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL2799 0.98 PTGS2 (1.00) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL418230 0.97 PTGS2 (0.97) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL22370200 0.97 PTGS2 (0.97) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL3184302 0.97 PTGS2 (0.97) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL1231246 0.97 PTGS2 (0.97) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL22129258 0.97 PTGS2 (0.97) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL24010 0.97 PTGS2 (0.97) PTGS2CXCL8TTRPTGS1AKR1B10
Diclofenac SCHEMBL4614418 0.97 PTGS2 (0.97) PTGS2CXCL8TTRPTGS1AKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101433544-B External-use pharmaceutical composition formulation with antiphlogistic, swelling-dispersing and analgesic functions, and use JIANGSU ZEUKOV PHARMACEUTICAL SCIENCE & TECHNOLOGY INC 2012-07-18 CN claimed
CN-101433544-A External-use pharmaceutical composition formulation with antiphlogistic, swelling-dispersing and analgesic functions, and use JIANGSU ZEUKOV PHARMACEUTICAL (CN) 2009-05-20 CN claimed
US-20070213406-A1 Anti-Inflammatory Analgesic External Aqueus Liquid Preparation DOJIN IYAKU-KAKO CO., LTD (JP) 2007-09-13 US claimed
EP-0600395-B1 Antinflammatory and analgesic diclofenac gel preparation SS PHARMACEUTICAL CO (JP) 2000-03-15 EP claimed
US-5422102-A Diclofenac or salt with nonionic polymer of hydroxypropyl and/or hydroxyethyl cellulose; percutaneous adsorption SS PHARMACEUTICAL CO., LTD. (JP) 1995-06-06 US claimed
EP-0600395-A1 Antinflammatory and analgesic diclofenac gel preparation SS PHARMACEUTICAL CO., LTD. (JP) 1994-06-08 EP claimed
JP-10182450-A None JP disclosed
WO-2024062349-A1 HYDROALCOHOLIC TOPICAL DICLOFENAC FORMULATIONS HALEON CH SARL (CH) 2024-03-28 WO disclosed
WO-2024062348-A1 HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC HALEON CH SARL (CH) 2024-03-28 WO disclosed
EP-4342449-A1 HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC Haleon CH SARL (CH) 2024-03-27 EP disclosed
EP-4342450-A1 HYDROALCOHOLIC TOPICAL DICLOFENAC FORMULATIONS Haleon CH SARL (CH) 2024-03-27 EP disclosed
WO-2020133015-A1 CYPYRAFLUONE MONOISOPROPYLAMINE SALT D CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF 青岛清原化合物有限公司 2020-07-02 WO disclosed
WO-2020133013-A1 CRYSTALLINE FORM B OF CYPYRAFLUONE ISOPROPYLAMINE SALT, AND PREPARATION METHOD AND USE THEREFOR 青岛清原化合物有限公司 2020-07-02 WO disclosed
US-20070213406-A1 Anti-Inflammatory Analgesic External Aqueus Liquid Preparation DOJIN IYAKU-KAKO CO., LTD (JP) 2007-09-13 US disclosed
CN-1200696-C Patch containing anti-inflammatory agent HISAMITSU PHARMACEUTICAL CO (JP) 2005-05-11 CN disclosed
US-20030149383-A1 Patch containing anti-inflammatory agent HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2003-08-07 US disclosed
CN-1424908-A Patch containing anti-inflammatory agent HISAMITSU PHARMACEUTICAL CO (JP) 2003-06-18 CN disclosed
EP-1277466-A1 PATCH CONTAINING ANTI-INFLAMMATORY AGENT HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2003-01-22 EP disclosed
JP-H10182450-A COMPOSITION FOR EXTERNAL USE SS PHARMACEUT CO LTD 1998-07-07 JP disclosed
US-5350769-A Sodium or ammonium diclofenac, a nonionic polymer, an ester of a diacid and an lower alcohol SS PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed